Oncology/Hematology
News, opinions and meeting coverage in oncology/hematology.
Latest in Oncology/Hematology
In multinational cohort, cancer incidence with pulled drug no different than other H2RAs
Strategy tied to better outcomes but fails to meet primary goal of phase II trial
In a phase III trial, momelotinib reduced anemia, constitutional symptoms, and splenomegaly
Study shows similar incidence rates to general population, unlike for those with erosive GERD
In a phase III trial, momelotinib reduced anemia, constitutional symptoms, and splenomegaly
Study shows similar incidence rates to general population, unlike for those with erosive GERD
Oncology/Hematology Case Studies
Man with a first-degree relative with CRC initially only agreed to stool-based testing

The cause lies in a lengthy history of cancer treatment, confirmed by histopathology analysis

Consistently low PSA levels failed to signal metastasis

More in Oncology/Hematology
Technique reduces risk of severe lung toxicity and radiation to the heart compared with 3D-CRT

Premenopausal bilateral oophorectomy tied to higher odds of arthritis, sleep apnea, and more

Osimertinib plus chemotherapy improved PFS by nearly 9 months versus targeted agent alone

Best outcomes with transplantation, but non-transplant patients also benefited from quizartinib
